RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
RT @alarjosan: @FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Se…
@FarazKh65499316 https://t.co/e1oAj0zabE the molecular profile influence in the prognosis instead of make a good surgery. Selection is the key!!! @AnnSurgOncol @EYSAC1 @operarelcancer @aec @SPeritoneum
RT @alarjosan: Take in your mind the molecular profile RAS to select the patients for CRS HIPEC and colon peritoneal metastasis. Use the mo…
RT @drfatihavsar: KOLON PERİTON METASTAZINDA MPSDSS-RAS/CRS HIPEC
KOLON PERİTON METASTAZINDA MPSDSS-RAS/CRS HIPEC
RT @alarjosan: Take in your mind the molecular profile RAS to select the patients for CRS HIPEC and colon peritoneal metastasis. Use the mo…
RT @alarjosan: Take in your mind the molecular profile RAS to select the patients for CRS HIPEC and colon peritoneal metastasis. Use the mo…
Take in your mind the molecular profile RAS to select the patients for CRS HIPEC and colon peritoneal metastasis. Use the modified PSDSS-RAS. @HUReinaSofia @operarelcancer @AnnSurgOncol @SPeritoneum @DeliaCortesGuir @AndreasBrandl8 @oliviawriting @SWexner
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @DrGeorgeSalti: Excited to be part of this international collaborative effort @HIPEC @peritoneal @AnnSurgOncol https://t.co/2QlVX4xj8p…
RT @DrGeorgeSalti: Excited to be part of this international collaborative effort @HIPEC @peritoneal @AnnSurgOncol https://t.co/2QlVX4xj8p…
#PubSaludMurcia RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score https://
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @operarelcancer: Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía…
Tener una mutación en el gen RAS disminuye la supervivencia promedio del paciente que ha superado con éxito una cirugía citorreductora + HIPEC para tratar su metástasis peritoneal. Investigación del Dr. @alarjosan et alii en https://t.co/YYrQsw4EC7
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RT @alarjosan: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: M…
RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Metastasis: Modification Proposal of the Peritoneal Surface Disease Severity Score. @operarelcancer @me4_so @SPeritoneum https://t.co/O6JpO
RT @bibliosalut: #PublicaSAlutIB La Unitat de Cirurgia Oncològica i Pancreàtica de Son Espases ha participat en una modificació del periton…
#PublicaSAlutIB La Unitat de Cirurgia Oncològica i Pancreàtica de Son Espases ha participat en una modificació del peritoneal surface disease severity score (PSDSS) https://t.co/rKjo4HFWtU @RMoralesSoriano @cgdsonespases @sobacir https://t.co/uqVynEPtgw ht
RT @infosalut: #PublicaSalutIB La Unidad de Cirugía Oncológica y Pancreática de @SonEspases ha participado en una modificación del peritone…
#PublicaSalutIB La Unidad de Cirugía Oncológica y Pancreática de @SonEspases ha participado en una modificación del peritoneal surface disease severity score (PSDSS) https://t.co/sDnuo2TYRV @RMoralesSoriano @CGdeLizardi https://t.co/8G4vvwpBjx https://t.co
RT @debby_keller: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Mets: A Mo…
RT @debby_keller: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Mets: A Mo…
RT @debby_keller: RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Mets: A Mo…
RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and HIPEC of Colorectal Peritoneal Mets: A Modification Proposal of the Peritoneal Surface Disease Severity Score @AnnSurgOncol @SPeritoneum #colorectalsurgery #colorectalresearch
RT @DrGeorgeSalti: Excited to be part of this international collaborative effort @HIPEC @peritoneal @AnnSurgOncol https://t.co/2QlVX4xj8p…
RT @DrGeorgeSalti: Excited to be part of this international collaborative effort @HIPEC @peritoneal @AnnSurgOncol https://t.co/2QlVX4xj8p…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
Excited to be part of this international collaborative effort @HIPEC @peritoneal @AnnSurgOncol https://t.co/2QlVX4xj8p https://t.co/AYHHMF3WcN
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @sobacir: Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros…
RT @Vanahupa: Happy for our unit to have collaborated in this study. Thanks @alarjosan for the opportunity!! @SCanariaCirugia #HUNSC #teamw…
RT @Vanahupa: Happy for our unit to have collaborated in this study. Thanks @alarjosan for the opportunity!! @SCanariaCirugia #HUNSC #teamw…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
Happy for our unit to have collaborated in this study. Thanks @alarjosan for the opportunity!! @SCanariaCirugia #HUNSC #teamwork in science!!
felicidades @cgdsonespases @RMoralesSoriano @aecirujanos @operarelcancer
Enhorabuena al Dr @RMoralesSoriano por su reciente publicación en @AnnSurgOncol en colaboración con @alarjosan y otros centros @GECOP_. https://t.co/uvhuayzvJI
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RT @alarjosan: RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carc…
RAS mutations decreases survival after CRS and #HIPEC . A new RAS-PSDSS score is proposed to select patients with colon carcinomatosis @operarelcancer @aecirujanos @GECOP_ @ESSOnews @SPeritoneum @HUReinaSofia @me4_so @SWexner @DeliaCortesGuir @FaheezM htt